Safety and Bioavailability of IV and SC LBR-101
Study Title
- Safety and Bioavailability of IV and SC LBR-101
Teva Identifier
- LBR-101-011
ClinicalTrials.gov Identifier
- NCT01991509
Study Status
- Completed
Trial Condition(s)
- Bioavailability and Pharmacokinetics
Interventions
- Biological: LBR-101 IV | Biological: LBR-101 SC
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 60 Years
Trial Duration
- 10/01/2013 - 01/01/2015
Phase
- Phase 1
Study Type
Interventional
